McIlvenny Patrick 4
4 · Horizon Therapeutics Public Ltd Co · Filed Jan 6, 2023
Insider Transaction Report
Form 4
McIlvenny Patrick
Chief Accounting Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2023-01-05+7,973→ 10,463 total - Tax Payment
Ordinary Shares
2023-01-05$113.24/sh−4,147$469,606→ 6,316 total - Award
Restricted Stock Units (RSU)
2023-01-04+11,498→ 11,498 total→ Ordinary Shares (11,498 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2023-01-05−3,871→ 0 total→ Ordinary Shares (3,871 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2023-01-05−2,198→ 2,198 total→ Ordinary Shares (2,198 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2023-01-05−1,904→ 3,809 total→ Ordinary Shares (1,904 underlying)
Footnotes (5)
- [F1]Each RSU represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The RSUs vest 1/3rd annually on each anniversary of January 5, 2023.
- [F3]The final tranche of ordinary shares subject to the RSU vested on January 5, 2023.
- [F4]The remaining ordinary shares subject to the RSU vest on January 5, 2024.
- [F5]The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025